Brought to you by Exelixis 
If you are interested in learning more about CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab), please join our educational presentation: Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab) on April 22, 2021 at 5:00PM EST 

  • Disease State Overview 
  • New combination treatment for appropriate patients  
  • Dosing and administration information, including dose adjustment guidance 
  • Management of select adverse reactions 
  • Support information and access services